LEAH STONE

Policies related to laboratory developed tests.

Including issues related to the blood supply in the reauthorization of the Pandemic and All-Hazards Preparedness Act.

The "Prepare for and Respond to Existing Viruses, Emerging New Threats, and Pandemics Act" or the "PREVENT Pandemics Act" (S. 3799) on issues pertaining to the blood supply.

Appropriations for National Institutes of Health in a FY 2022 omnibus appropriation bill.

Supporting policies intended strengthen the blood supply.

Improving Access to Transfusion Care for Hospice Patients Act of 2021 (S. 2566), and supporting a CMMI demonstration project that would establish a separate payment for blood transfusions furnished to patients receiving hospice care.

-Advancing policies that support the blood supply. -Cures 2.0 discussion draft and Advanced Research Projects Agency for Health (ARPA-H) request for information.

Improving Access to Transfusion Care for Hospice Patients Act of 2021 (S. 2566), and supporting a CMMI demonstration project that would establish a separate payment for blood transfusions furnished to patients receiving hospice care. Supporting a bill that would authorize the Centers for Medicare and Medicaid Services (CMS) to develop a program for Medicaid beneficiaries to improve access to comprehensive outpatient care for individuals with sickle cell disease.

Advancing policies that support the blood supply.

Support for innovative payment models for novel biotherapies.

Appropriations for the Center for Biologics Evaluation and Research at the Food and Drug Administration in the FY 2022 appropriations bill for the Departments of Agriculture, Rural Development, Food and Drug Administration, and Related Agencies. Appropriations for implementation of section 3226 of the Coronavirus Aid, Relief, and Economic Security Act (P.L. 116-136)

Advancing policies that support the blood supply.

Appropriations for National Institutes of Health and the Centers for Disease Control and Prevention in the FY 2022 Departments of Labor, HHS, Education and Related Agencies Appropriations Bill.

Support for (1) research and activities related to blood donor awareness and engagement; (2) a data infrastructure that capture real-time data on the blood supply; and (3) a public-private partnership to advance policy solutions for the U.S. blood system.

Coronavirus Aid, Relief, and Economic Security Act (H.R. 748) on issues pertaining to the blood supply.

Support for the Patient Access to Cellular Transplant (PACT) Act (S. 1286/H.R. 2498).

Appropriations for the Food and Drug Administration in the fiscal year 2020 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies bill.

Request that the Senate advance the Pandemic and All-Hazards Preparedness Advancing Innovation Act (PAHPAI, H.R. 269).

Appropriations for National Institutes of Health in the FY 2020 Departments of Labor, HHS, Education and Related Agencies Appropriations Bill.

The Pandemic and All-Hazards Preparedness Advancing Innovation Act (S. 2852/H.R. 6378), which includes requirements that (1) the Assistant Secretary for Preparedness and Response consult with stakeholders to develop guidelines for regional public health emergency preparedness and response systems and (2) the Department of Health and Human Services submit a report to Congress containing recommendations related to maintaining an adequate national blood supply.

The Pandemic and All-Hazards Preparedness Advancing Innovation Act (S. 2852/H.R. 6378), which includes requirements that (1) the Assistant Secretary for Preparedness and Response consult with stakeholders to develop guidelines for regional public health emergency preparedness and response systems and (2) the Department of Health and Human Services submit a report to Congress containing recommendations related to maintaining an adequate national blood supply.

S. 2852, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018 and House bill reauthorizing the Pandemic and All-Hazards Preparedness Act.

Appropriations for certain preparedness programs in the FY 2019 Departments of Labor, HHS, Education and Related Agencies Appropriations Bill.

Letter to Congress supporting the Food and Drug Administration's process related to a pending guidance entitled,Bacterial Risk Control Strategies for Blood Collection Establishments and Transfusion Services to Enhance the Safety and Availability of Platelets for Transfusion.

Appropriations for National Institutes of Health in the FY 2019 Departments of Labor, HHS, Education and Related Agencies Appropriations Bill. Appropriations for the expansion of the C.W. Bill Young Transplantation Program's Stem Cell Outcomes Database to enable the creation of a national registry for regenerative cell therapies in the FY 2019 Departments of Labor, HHS, Education and Related Agencies Appropriations Bill. Appropriations for certain preparedness programs in the FY 2019 Departments of Labor, HHS, Education and Related Agencies Appropriations Bill.

Sickle Cell Disease Surveillance, Prevention, and Treatment Act of 2018 (H.R. 2410/ S. 2465), which would reauthorize a sickle cell disease prevention and treatment demonstration program and provide for sickle cell disease research, surveillance, prevention, and treatment.

H.R. 4215 (Protect Access to Cellular Transplant (PACT) Act), which would require Medicare to make separate payments to hospitals to cover costs associated with donor search and acquisition for hematopoietic cell transplantation.

H.R. 4215 (Protect Access to Cellular Transplant (PACT) Act), which would require Medicare to make separate payments to hospitals to cover costs associated with donor search and acquisition for hematopoietic cell transplantation.

blood safety issues

Appropriations for National Institutes of Health in the Departments of Labor, HHS, Education and Related Agencies Appropriations Act of 2017

blood safety issues

Appropriations for National Institutes of Health in the Departments of Labor, HHS, Education and Related Agencies Appropriations Act of 2017

Continuing Appropriations and Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2017, and Zika Response and Preparedness Act, H.R. 5325 Cost-recovery regarding implementation of guidance issued by the Food and Drug Administration entitled, "Revised Recommendations for Reducing the Risk of Zika Virus Transmission by Blood and Blood Components"

Continuing Appropriations and Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2017, and Zika Response and Preparedness Act, H.R. 5325 Cost-recovery regarding implementation of guidance issued by the Food and Drug Administration entitled, "Revised Recommendations for Reducing the Risk of Zika Virus Transmission by Blood and Blood Components"

Continuing Appropriations and Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2017, and Zika Response and Preparedness Act, H.R. 5325 Cost-recovery regarding implementation of guidance issued by the Food and Drug Administration entitled, "Revised Recommendations for Reducing the Risk of Zika Virus Transmission by Blood and Blood Components"

Continuing Appropriations and Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2017, and Zika Response and Preparedness Act, H.R. 5325 Cost-recovery regarding implementation of guidance issued by the Food and Drug Administration entitled, "Revised Recommendations for Reducing the Risk of Zika Virus Transmission by Blood and Blood Components"